Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Price Target at $111.50

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $111.50.

A number of research analysts recently issued reports on USPH shares. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Finally, JMP Securities initiated coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target for the company.

Insider Buying and Selling

In related news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.70% of the stock is owned by company insiders.

Institutional Trading of U.S. Physical Therapy

Large investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets grew its holdings in shares of U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after purchasing an additional 12,445 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in U.S. Physical Therapy by 57.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after purchasing an additional 956 shares during the last quarter. State Street Corp grew its stake in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after buying an additional 99,244 shares in the last quarter. Stifel Financial Corp increased its holdings in shares of U.S. Physical Therapy by 12.1% in the 3rd quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock worth $4,838,000 after buying an additional 6,154 shares during the last quarter. Finally, Harbor Capital Advisors Inc. raised its position in U.S. Physical Therapy by 113.4% during the third quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company’s stock valued at $1,370,000 after purchasing an additional 8,604 shares during the period.

U.S. Physical Therapy Trading Up 2.5 %

Shares of U.S. Physical Therapy stock opened at $81.37 on Monday. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The company’s fifty day simple moving average is $87.77 and its 200-day simple moving average is $87.59. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market capitalization of $1.23 billion, a PE ratio of 86.56, a P/E/G ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. As a group, equities analysts anticipate that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.21%. The ex-dividend date of this dividend is Friday, March 14th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.